American Society of Addiction Medicine
The Voice of Addiction Medicine
Apply from September 15 - December 15 to become an ASAM Distinguished Fellow!
Register now for the 2016 Annual Conference and pre-conference courses!
Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry...
On Monday, November 16, ASAM's Dr. Richard Soper will take the stage at the AMA Interim Meeting in Atlanta to discuss stigma related to addiction.
More than ten medical societies, eight federal agencies and other patient and payer organizations met on September 24 to discuss strategies to help accelerate the adoption of ASAM's newly released National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.
The ASAM National Practice Guideline and associated resources provide information on evidence-based treatment of opioid use disorder.
Webinars about the new National Practice Guideline, ER/LA Opioids and more. Many are free sessions with free CME.
Upcoming Risk Evaluation and Mitigation Strategies (REMS) training for prescribers of Extended Release/Long Acting (ER/LA) Opioids provided in a 3 hour course.
Half online, half live course provides 8 hours of CME training for eligibility to obtain a DEA waiver to prescribe buprenorphine.
An 8 hour online DEA waiver training course and a 4 hour online SBIRT course.
Our nationwide directory of addiction medicine professionals.
Worldwide, tobacco use causes more than 5 million deaths per year.
© 2015 American Society of Addiction Medicine. All rights reserved.
4601 N. Park Avenue, Upper Arcade #101, Chevy Chase, MD 20815
Phone: 301-656-3920 |
Fax: 301-656-3815 |
Association Web Design by Matrix Group International, Inc.
Connect With Us